Anti-cytokine vaccination: A new biotherapy of autoimmunity?

Autoimmunity Reviews

Volumn 11, Issue 11, 2012, Pages 785-786

  Semerano, Luca ^a,b   Assier, Eric ^a   Boissier, Marie Christophe ^a,b  

^a Laboratory Educations and Health Practices   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

Cytokines; Kinoids; Vaccination

Indexed keywords

ALPHA INTERFERON KINOID; AUTOANTIBODY; CYTOKINE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA KINOID; UNCLASSIFIED DRUG; VASCULOTROPIN;

CROHN DISEASE; DRUG SAFETY; DRUG TARGETING; HUMAN; HUMORAL IMMUNITY; IMMUNOTHERAPY; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOKINES; HUMANS; IMMUNOTHERAPY, ACTIVE; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865357576     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.02.003     Document Type: Review

References (22)

1. Delavallée L., Duvallet E., Semerano L., Assier E., Boissier M.C. Anti-cytokine vaccination in autoimmune diseases. Swiss Med Wkly 2010, 140:w13108.
2. Bizzini B., Achour A. "Kinoids": the basis for anticytokine immunization and their use in HIV infection. Cell Mol Biol (Noisy-le-Grand) 1995, 41:351-356.
3. Uyttenhove C., Van Snick J. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 2006, 36:2868-2874.
4. Link A., Bachmann M.F. Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines. Immunotherapy 2010, 2:561-574.
5. Buch M.H., Rubbert-Roth A., Ferraccioli G. To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50. Autoimmun Rev Oct. 22 2011, [Epub ahead of print].
6. Gaujoux-Viala C., Mouterde G., Baillet A., Claudepierre P., Fautrel B., Le Loët X., et al. Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint Bone Spine Jun 14 2011, [Epub ahead of print].
7. Hetland M.L., Christensen I.J., Tarp U., Dreyer L., Hansen A., Hansen I.T., et al. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum 2010, 62:22-32.
8. Semerano L., Assier E., Delavallée L., Boissier M.C. Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis. Expert Opin Biol Ther 2011, 11:545-550.
9. Le Buanec H., Delavallée L., Bessis N., Paturance S., Bizzini B., Gallo R., et al. TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation. Proc Natl Acad Sci USA 2006, 103:19442-19447.
10. Delavallée L., Le Buanec H., Bessis N., Assier E., Denys A., Bizzini B., et al. Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha. Ann Rheum Dis 2008, 67:1332-1338.
11. Delavallée L., Semerano L., Assier E., Vogel G., Vuagniaux G., Laborie M., et al. Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis. Arthritis Res Ther 2009, 11:R195.
12. Biton J., Semerano L., Delavallée L., Lemeiter D., Laborie M., Grouard-Vogel G., et al. Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. J Immunol 2011, 186:3899-3910.
13. Bertin-Maghit S.M., Capini C.J., Bessis N., Chomilier J., Muller S., Abbas A., et al. Improvement of collagen-induced arthritis by active immunization against murine IL-1beta peptides designed by molecular modelling. Vaccine 2005, 23:4228-4335.
14. Chackerian B., Lowy D.R., Schiller J.T. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J Clin Invest 2001, 108:415-423.
15. Capini C.J., Bertin-Maghit S.M., Bessis N., Haumont P.M., Bernier E.M., Muel E.G., et al. Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. Vaccine 2004, 22:3144-3153.
16. Spohn G., Guler R., Johansen P., Keller I., Jacobs M., Beck M., et al. A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis. J Immunol 2007, 178:7450-7457.
17. Ratsimandresy R.A., Duvallet E., Assier E., Semerano L., Delavallée L., Bessis N., et al. Active immunization against IL-23p19 improves experimental arthritis. Vaccine 2011, 29:9329-9336.
18. Marrelli A., Cipriani P., Liakouli V., Carubbi F., Perricone C., Perricone R., et al. Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?. Autoimmun Rev 2011, 10:595-598.
19. Semerano L., Clavel G., Assier E., Denys A., Boissier M.C. Blood vessels, a potential therapeutic target in rheumatoid arthritis ?. Joint Bone Spine 2011, 78:118-123.
20. Assier E., Semerano L., Delavallée L., Grouard-Vogel G., Bernier E., Zagury D., et al. Active Immunization against VEGF Improves Joint Inflammation and Destruction in Collagen-Induced Arthritis. Arthritis Rheum 2009, 60(Suppl 10):662. [abstract].
21. Zagury D., Le Buanec H., Mathian A., Larcier P., Burnett R., Amoura Z., et al. IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc Natl Acad Sci USA 2009, 106:5294-5299.
22. Mathian A., Amoura Z., Adam E., Colaone F., Hoekman M.F., Dhellin O., et al. Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus. Ann Rheum Dis 2011, 70:1138-1143.